20-41061479-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_003286.4(TOP1):c.144G>A(p.Lys48Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00353 in 1,599,296 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0023 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 13 hom. )
Consequence
TOP1
NM_003286.4 synonymous
NM_003286.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.20
Genes affected
TOP1 (HGNC:11986): (DNA topoisomerase I) This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This enzyme catalyzes the transient breaking and rejoining of a single strand of DNA which allows the strands to pass through one another, thus altering the topology of DNA. This gene is localized to chromosome 20 and has pseudogenes which reside on chromosomes 1 and 22. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 20-41061479-G-A is Benign according to our data. Variant chr20-41061479-G-A is described in ClinVar as [Benign]. Clinvar id is 708476.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.2 with no splicing effect.
BS2
High AC in GnomAd4 at 344 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOP1 | NM_003286.4 | c.144G>A | p.Lys48Lys | synonymous_variant | 3/21 | ENST00000361337.3 | NP_003277.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOP1 | ENST00000361337.3 | c.144G>A | p.Lys48Lys | synonymous_variant | 3/21 | 1 | NM_003286.4 | ENSP00000354522.2 | ||
TOP1 | ENST00000681058.1 | n.298G>A | non_coding_transcript_exon_variant | 3/20 | ||||||
TOP1 | ENST00000681113.1 | n.144G>A | non_coding_transcript_exon_variant | 3/23 | ENSP00000505788.1 |
Frequencies
GnomAD3 genomes AF: 0.00226 AC: 344AN: 152194Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
344
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00249 AC: 549AN: 220558Hom.: 1 AF XY: 0.00266 AC XY: 317AN XY: 119158
GnomAD3 exomes
AF:
AC:
549
AN:
220558
Hom.:
AF XY:
AC XY:
317
AN XY:
119158
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00366 AC: 5300AN: 1446984Hom.: 13 Cov.: 30 AF XY: 0.00364 AC XY: 2616AN XY: 718604
GnomAD4 exome
AF:
AC:
5300
AN:
1446984
Hom.:
Cov.:
30
AF XY:
AC XY:
2616
AN XY:
718604
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00226 AC: 344AN: 152312Hom.: 1 Cov.: 32 AF XY: 0.00208 AC XY: 155AN XY: 74488
GnomAD4 genome
AF:
AC:
344
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
155
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at